Responses of rat substantia nigra compacta neurones to L‐DOPA

1 The electrophysiological actions of l‐DOPA were studied on substantia nigra dopamine‐containing neurones by use of intracellular recordings, current and voltage clamp, in vitro. 2 l‐DOPA (3–300 μm), applied by superfusion, decreased the spontaneous firing activity of the neurones, hyperpolarized the membrane potential and produced an outward current. 3 These effects of l‐DOPA were graded and were antagonized by sulpiride, a D2‐receptor antagonist. 4 The l‐DOPA activated membrane hyperpolarization persisted in slices exposed to tetrodotoxin while it was markedly reduced or abolished in solutions with no calcium plus cobalt (2 mm). 5 In slices treated with carbidopa, an inhibitor of the aromatic amino acid decarboxylase enzyme, the actions of l‐DOPA were greatly reduced. 6 We propose that l‐DOPA inhibits the firing of substantia nigra zona compacta neurones by being converted to dopamine which is then released by these cells.

[1]  P. Calabresi,et al.  The mechanism of amphetamine‐induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro , 1989, British journal of pharmacology.

[2]  P. Calabresi,et al.  Physiology and pharmacology of dopamine D2‐receptors , 1989, Neurology.

[3]  N. Mercuri,et al.  Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  J. Woodward,et al.  Calcium-dependent and -independent release of endogenous dopamine from rat striatal synaptosomes , 1988, Brain Research.

[5]  W R Woodward,et al.  Does an inhibitory action of levodopa contribute to motor fluctuations? , 1988, Neurology.

[6]  P. Calabresi,et al.  Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: Intracellular studies from naive and catecholamine-depleted rats , 1988, Neuroscience.

[7]  N. Mercuri,et al.  On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. , 1988, The Journal of physiology.

[8]  G. Robertson,et al.  Evidence that the substantia nigra is a site of action for l-DOPA , 1988, Neuroscience Letters.

[9]  L. Cubeddu,et al.  Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals. , 1988, The Journal of pharmacology and experimental therapeutics.

[10]  N. Mercuri,et al.  Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. , 1987, The Journal of physiology.

[11]  T. Chase,et al.  Levodopa methyl ester treatment of Parkinson's disease , 1987, Neurology.

[12]  U. Ungerstedt,et al.  Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis , 1986, Brain Research.

[13]  J. Woodward,et al.  Correlation of rates of calcium entry and endogenous dopamine release in mouse striatal synaptosomes , 1985, Brain Research.

[14]  E. Melamed,et al.  Suppression of L‐dopa‐induced circling in rats with nigral lesions by blockade of central dopa‐decarboxylase , 1984, Neurology.

[15]  R. Pinnock The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra , 1984, British journal of pharmacology.

[16]  R. Pinnock Sensitivity of compacta neurones in the rat substantia nigra slice to dopamine agonists. , 1983, European journal of pharmacology.

[17]  G. Rinaldi,et al.  Does acutel-DOPA increase active release of dopamine from dopaminergic neurons? , 1983, Brain Research.

[18]  E. Melamed,et al.  Dopamine release in rat striatum after administration ofl-DOPA as studied with in vivo electrochemistry , 1981, Brain Research.

[19]  J. Glowinski,et al.  Dendritic release of dopamine in the substantia nigra , 1981, Nature.

[20]  R. Wurtman,et al.  Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease , 1980, Nature.

[21]  J. Glowinski,et al.  Release of dopamine in vivo from cat substantia nigra , 1977, Nature.

[22]  T. Jessell,et al.  Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.

[23]  J. Korf,et al.  Dopamine release in substantia nigra? , 1976, Nature.

[24]  O. Hornykiewicz The mechanisms of action of L-dopa in Parkinson's disease. , 1974, Life sciences.

[25]  R. Roth,et al.  Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. , 1973, Nature: New biology.

[26]  B. Bunney,et al.  CENTRAL DOPAMINERGIC NEURONS: NEUROPHYSIOLOGICAL IDENTIFICATION AND RESPONSES TO DRUGS* , 1973 .

[27]  T. Chase,et al.  L-Dopa-Induced Release of Cerebral Monoamines , 1970, Science.

[28]  George C. Cotzias,et al.  Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.

[29]  O. Hornykiewicz Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.

[30]  A. Barbeau The use of L-DOPA in Parkinson's disease: a 20 year follow-up , 1981 .